高剂量乙肝疫苗免疫策略成本效益分析
Cost-benefit Analysis of High-dose Immunization Strategy of Infant Hepatitis B Vaccination
-
摘要: 目的探讨我国经济发达地区乙肝疫苗接种的最佳免疫策略.方法以北京市东城区防疫站1991~1998年乙肝疫苗免疫接种及乙肝发病、死亡资料及费用调查为基础,对新生儿高剂量的免疫策略进行成本效益分析.结果1991年对全部新生儿实施预防接种,投入疫苗接种成本3424万元,因免疫接种而避免急、慢性乙肝及肝癌而节省费用59179万元,可获4992万元的净效益(NB),效益成本比(BCR)为15.58.结论现行免疫接种方案经济效益显着,建议经济发达地区仍实行高剂量免疫策略.Abstract: ObjectiveTo study the best vaccination strategy of hepat itis B vaccine in economically advanced r egion in China.MethodsCost-benefit analysis(CBA)was used to evaluate the high-dose immunization str ategy of infant hepatitis B vaccination in Dongcheng distr ict of Beijing.ResultsAlmos of 5.917 9 million Yuan(RMB)could be saved if putting into 0.3424 million Yuan(RMB)for the cost of the vaccination;the NB was 4.992 million Yuan(RMB)and the BCR was 15.58.ConclusionThe economic benefit of the curr ent immunization strategy was significant.The cost of screening and discount rate could change BCR greatly.
下载: